Cargando…

Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies

Detalles Bibliográficos
Autores principales:	Hüser, Laura, Altevogt, Peter, Utikal, Jochen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422197/ https://www.ncbi.nlm.nih.gov/pubmed/30899437 http://dx.doi.org/10.18632/oncotarget.26718

Ejemplares similares

HER3-Receptor-Mediated STAT3 Activation Plays a Central Role in Adaptive Resistance toward Vemurafenib in Melanoma
por: Hüser, Laura, et al.
Publicado: (2020)

New role of ID3 in melanoma adaptive drug-resistance
por: Sachindra,, et al.
Publicado: (2017)

Targeted Therapy-Resistant Melanoma Cells Acquire Transcriptomic Similarities with Human Melanoblasts
por: Larribère, Lionel, et al.
Publicado: (2018)

IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma
por: Weber, Rebekka, et al.
Publicado: (2020)

Melanoma Cellular Plasticity
por: Novak, Daniel, et al.
Publicado: (2022)

STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice
por: Bitsch, Rebekka, et al.
Publicado: (2022)

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
por: Petrova, Vera, et al.
Publicado: (2020)

Secretogranin II influences the assembly and function of MHC class I in melanoma
por: Steinfass, Tamara, et al.
Publicado: (2023)

SOX5 is involved in balanced MITF regulation in human melanoma cells
por: Kordaß, Theresa, et al.
Publicado: (2016)

SOX2 and cancer: current research and its implications in the clinic
por: Weina, Kasia, et al.
Publicado: (2014)

STAT3 Relays a Differential Response to Melanoma-Associated NRAS Mutations
por: Kim, James, et al.
Publicado: (2020)

NF1-Dependent Transcriptome Regulation in the Melanocyte Lineage and in Melanoma
por: Larribère, Lionel, et al.
Publicado: (2021)

T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cells
por: Granados, Karol, et al.
Publicado: (2020)

Stem Cell-Derived Models of Neural Crest Are Essential to Understand Melanoma Progression and Therapy Resistance
por: Larribère, Lionel, et al.
Publicado: (2019)

Mesoderm-specific Stat3 deletion affects expression of Sox9 yielding Sox9-dependent phenotypes
por: Hall, Michael D., et al.
Publicado: (2017)

Tackling malignant melanoma epigenetically: histone lysine methylation
por: Orouji, Elias, et al.
Publicado: (2018)

New Biomarkers in Cancers
por: Novak, Daniel, et al.
Publicado: (2021)

Update on GNA Alterations in Cancer: Implications for Uveal Melanoma Treatment
por: Larribère, Lionel, et al.
Publicado: (2020)

p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells
por: Pietrobono, Silvia, et al.
Publicado: (2022)

Radiation resistance in breast cancer: are CD44(+)/CD24(-)/proteosome(low)/PKH26(+ )cells to blame?
por: Nakshatri, Harikrishna
Publicado: (2010)

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
por: Fleming, Viktor, et al.
Publicado: (2018)

Systemic Therapy of Non-Resectable Metastatic Melanoma
por: Orouji, Azadeh, et al.
Publicado: (2010)

SOX9 is a dose-dependent metastatic fate determinant in melanoma
por: Yang, Xintao, et al.
Publicado: (2019)

Reduced Placental CD24 in Preterm Preeclampsia Is an Indicator for a Failure of Immune Tolerance
por: Sammar, Marei, et al.
Publicado: (2021)

Targeting STAT6 in PMBL
por: Leroy, Karen, et al.
Publicado: (2014)

Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas
por: Salnikov, A V, et al.
Publicado: (2013)

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
por: Groth, Christopher, et al.
Publicado: (2018)

STAT3 mediates resistance of CD44(+)CD24(−/low) breast cancer stem cells to tamoxifen in vitro
por: Wang, Xiaoyan, et al.
Publicado: (2012)

HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling
por: Arkhypov, Ihor, et al.
Publicado: (2022)

Targeting STAT3 and STAT5 in Cancer
por: de Araujo, Elvin D., et al.
Publicado: (2020)

Cellular Reprogramming—A Model for Melanoma Cellular Plasticity
por: Granados, Karol, et al.
Publicado: (2020)

Identification of CD24 as a marker for tumorigenesis of melanoma
por: Tang, Ming-Rui, et al.
Publicado: (2018)

Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression
por: Groth, Christopher, et al.
Publicado: (2021)

Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma
por: Huang, Lili, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
por: Weber, Rebekka, et al.
Publicado: (2018)

Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles
por: Arkhypov, Ihor, et al.
Publicado: (2020)

Modeling Preeclampsia In Vitro: Polymorphic Variants of STOX1-A/B Genes Can Downregulate CD24 in Trophoblast Cell Lines
por: Sammar, Marei, et al.
Publicado: (2022)

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
por: Ozbay Kurt, Feyza Gul, et al.
Publicado: (2023)

Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
por: Hernandez-Davies, Jenny E, et al.
Publicado: (2015)

Pyrotinib Targeted EGFR-STAT3/CD24 Loop-Mediated Cell Viability in TSC
por: Han, Xiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4gcuh72vaf14ushpsfk7l76d9a